Clinical trial
Cannabis for Spasticity in Multiple Sclerosis
NCT00260741 · Center for Medicinal Cannabis Research, Other · Terminated
Key facts
| NCT number | NCT00260741 |
|---|---|
| Title | Cannabis for Spasticity in Multiple Sclerosis |
| Official title | Cannabis for Spasticity in Multiple Sclerosis: A Placebo-Controlled Study |
| Lead sponsor | Center for Medicinal Cannabis Research, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Smoked Cannabis |
| Enrollment | 60 |
| Start date | Mar 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Dec 2, 2005 |
| Last update posted | Apr 4, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: